Term Name: EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor
Synonyms: activin receptor kinase inhibitor, activin receptor kinase inhibitors, ATP:[receptor-protein] phosphotransferase inhibitor, ATP:[receptor-protein] phosphotransferase inhibitors, EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitors, EC 2.7.11.30 inhibitor, EC 2.7.11.30 inhibitors, inhibitor of receptor protein serine/threonine kinase, receptor protein serine/threonine kinase (EC 2.7.11.30) inhibitor, receptor protein serine/threonine kinase (EC 2.7.11.30) inhibitors, receptor protein serine/threonine kinase inhibitor, receptor protein serine/threonine kinase inhibitors, receptor serine/threonine protein kinase inhibitor, receptor serine/threonine protein kinase inhibitors, receptor type I serine/threonine protein kinase inhibitor, receptor type I serine/threonine protein kinase inhibitors, receptor type II serine/threonine protein kinase inhibitor, receptor type II serine/threonine protein kinase inhibitors, STK13 inhibitor, STK13 inhibitors, TGF-beta kinase inhibitor, TGF-beta kinase inhibitors
Definition: An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the activity of receptor protein serine/threonine kinase (EC 2.7.11.30).
Ontology: ChEBI [CHEBI:137123]  ( EBI )

Relationships
is a type of: EC 2.7.11.* (protein-serine/threonine kinase) inhibitor
has subtype: TGFbeta receptor antagonist
inverse has_role: 2-(6-methylpyridin-2-yl)-N-(pyridin-4-yl)quinazolin-4-amine LDN-212854